Paolo Gallo, Marianna Silletta, Antonio De Vincentis, Federica Lo Prinzi, Francesca Terracciani, Giuseppina Di Fazio, Valentina Flagiello, Umberto Vespasiani Gentilucci, Raffaele Antonelli Incalzi, Antonio Picardi
{"title":"Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management.","authors":"Paolo Gallo, Marianna Silletta, Antonio De Vincentis, Federica Lo Prinzi, Francesca Terracciani, Giuseppina Di Fazio, Valentina Flagiello, Umberto Vespasiani Gentilucci, Raffaele Antonelli Incalzi, Antonio Picardi","doi":"10.1159/000521741","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sarcopenia is almost constantly observed in patients with cirrhosis and hepatocellular carcinoma (HCC).</p><p><strong>Summary: </strong>Chronic liver disease represents a unique pathophysiological scenario in which sarcopenia develops and all factors involved in the pathogenesis should be taken into account for an appropriate management of the disease. No properly designed intervention studies on this topic are available and, thus, no effective strategies have been developed for clinical practice. Apart from any targeted intervention, treatment, and optimization of liver disease is crucial.</p><p><strong>Key messages: </strong>In patients with cirrhosis and HCC, nutritional support to maintain and restore nutrition status, a targeted use of branched-chain amino acids and a guided physical exercise, should all be an integral part of the multidimensional assessment and tailored interventions.</p>","PeriodicalId":10047,"journal":{"name":"Chemotherapy","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000521741","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/12/31 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 6
Abstract
Background: Sarcopenia is almost constantly observed in patients with cirrhosis and hepatocellular carcinoma (HCC).
Summary: Chronic liver disease represents a unique pathophysiological scenario in which sarcopenia develops and all factors involved in the pathogenesis should be taken into account for an appropriate management of the disease. No properly designed intervention studies on this topic are available and, thus, no effective strategies have been developed for clinical practice. Apart from any targeted intervention, treatment, and optimization of liver disease is crucial.
Key messages: In patients with cirrhosis and HCC, nutritional support to maintain and restore nutrition status, a targeted use of branched-chain amino acids and a guided physical exercise, should all be an integral part of the multidimensional assessment and tailored interventions.
期刊介绍:
This journal publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamics properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide.